Tempus

Medical Director, Studies

Illinois, United States

Not SpecifiedCompensation
Senior (5 to 8 years)Experience Level
Full TimeJob Type
UnknownVisa
Healthcare, Biotechnology, PharmaceuticalsIndustries

Medical Director, Tempus Studies

Employment Type: Full-time

Salary: $275,000 - $310,000 (This range is applicable if the role is performed from Illinois and may vary for other locations such as California, Colorado, New York. Actual salary may vary based on qualifications and experience.)

Location Type: [Not Specified]


Position Overview

Passionate about precision medicine and advancing the healthcare industry? Tempus is seeking a Medical Director, Tempus Studies, to join our medical science team. This role is crucial for overseeing high-priority observational and interventional studies within the Tempus AI Studies group. As the primary clinical expert, you will be responsible for study design, protocol development, and study execution, collaborating with multidisciplinary teams and representing Tempus externally to biopharma collaborators and clinical researchers. You will also provide critical medical input to advance various Tempus AI initiatives by collaborating with other business units within the organization.


Responsibilities

  • Serve as a medical director for select programs to advance the business initiatives of Tempus Studies.
  • Oversee and lead the design and conduct of all stages of select studies.
  • Provide and source expert medical opinions to guide study design and protocol development across a variety of indications and treatment paradigms.
  • Lead multidisciplinary teams of trial operations and development experts to execute key study partnerships in line with appropriate timelines and milestones, providing medical and regulatory expertise as needed.
  • Represent Tempus Studies externally to launch studies and lead Site Initiation Visits (SIVs), scientific advisory boards, steering committees, and other academic and industry collaborations.

Requirements

  • MD degree with Oncology expertise OR MD with oncology clinical research experience.
  • 2+ years of clinical trials experience (in a clinical research organization, biotech/biopharma company, or as a primary investigator in an academic research setting).
  • Previous experience leading teams of trial development and operations personnel.
  • Experience with clinical trial data review & medical monitoring, site engagement, and clinical trial operations.
  • Strong written and verbal communication skills.
  • Familiarity with Good Clinical Practices (GCP) and regulatory interactions.

Company Information

Tempus' proprietary platform connects an entire ecosystem of real-world evidence to deliver real-time, actionable insights to physicians, providing critical information about the right treatments for the right patients, at the right time.

Tempus offers a full range of benefits, which may include incentive compensation, restricted stock units, medical and other benefits depending on the position.

We are an equal opportunity employer. We do not discriminate on the basis of race, religion, color, national origin, gender, sexual orientation, age, marital status, veteran status, or disability status.


Application Instructions

[Not Specified]

Skills

Study Design
Protocol Development
Clinical Trial Oversight
Multidisciplinary Team Leadership
Regulatory Expertise
Medical Expertise in Oncology or Relevant Indications
External Collaboration
Scientific Advisory Boards
Study Execution

Tempus

AI-driven healthcare data analysis platform

About Tempus

Tempus focuses on enhancing patient outcomes through the use of data and artificial intelligence in healthcare. The company offers a platform that analyzes medical data to provide insights for physicians, helping them make better treatment decisions. This platform also aids pharmaceutical and biotech companies in drug development by identifying new targets and assessing treatment effectiveness. For patients, Tempus identifies personalized therapy options, particularly in cancer care, where their research has shown increased opportunities for tailored treatments. They have developed a pan-cancer organoid platform and a liquid biopsy assay for profiling circulating tumor DNA. Tempus generates revenue by charging healthcare providers and companies for access to their platform and insights, setting them apart from competitors by their focus on personalized medicine and extensive cancer research.

Chicago, IllinoisHeadquarters
2015Year Founded
$894.9MTotal Funding
IPOCompany Stage
AI & Machine Learning, Biotechnology, HealthcareIndustries
1,001-5,000Employees

Benefits

Relocation Assistance
Company Equity
Performance Bonus

Risks

Competition from partners like Genialis may lead to conflicts of interest.
Ambry Genetics acquisition could pose financial risks if synergies aren't realized.
Technical challenges may arise in integration with Flatiron's OncoEMR platform.

Differentiation

Tempus uses AI to analyze clinical and molecular data for precision medicine.
Their platform aids in personalized treatment decisions for cancer patients.
Tempus collaborates with biotech firms to enhance drug development using real-world data.

Upsides

Increased AI adoption in healthcare boosts Tempus' partnerships and collaborations.
Acquisition of Ambry Genetics expands Tempus' genetic testing capabilities.
Integration with Flatiron's OncoEMR enhances precision in cancer treatment plans.

Land your dream remote job 3x faster with AI